ARTA
ALDR

A.R.T. Advisors’s Alder Biopharmaceuticals ALDR Stock Holding History

A.R.T. Advisors’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-31,739
Closed -$528K – 1850
2018
Q3 		$528K Sell
31,739
-54,088
-63% -$978K 0.02% 839
2018
Q2 		$1.36M Sell
85,827
-16,100
-16% -$245K 0.06% 506
2018
Q1 		$1.29M Buy
101,927
+24,800
+32% +$359K 0.05% 557
2017
Q4 		$883K Sell
77,127
-12,600
-14% -$141K 0.04% 672
2017
Q3 		$1.1M Buy
+89,727
New +$936K 0.06% 491
2015
Q1 		– Sell
-37,567
Closed -$1.09M – 1818
2014
Q4 		$1.09M Buy
37,567
+1,970
+6% +$35.4K 0.04% 611
2014
Q3 		$451K Buy
+35,597
New +$538K 0.02% 791

Other funds holding ALDR

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return